bioSyntagma has developed the mPrint,a platform which maps the microenvironment surrounding tumors,providing information which can be used to inform treatment decisions,preventing patient drug resistance and relapse,and furthering personalized medicine.


ANALYTICS AND BI; HEALTHCARE

View Details...